Search Browse Earnings

Arcellx, Inc. — SlamSEC

Arcellx, Inc.

Nasdaq:ACLX

Biological Products, (No Diagnostic Substances)·REDWOOD CITY, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$110.3M

+0.0% YoY

FY 2025

Adj. EBITDA

-$87.8M

-79.6% margin

FY 2025

Net Income

-$70.7M

-64.1% margin

FY 2025

EPS (Diluted)

-$1.47

FY 2025

Stock Price

$114.36

+0.0%

2026-03-10

52W Range

$47.86 – $114.80

P/E Ratio

-77.8x

Market Cap

$6.7B

Cash

$105.7M

FY 2025

Total Debt

—

Net Cash

$105.7M

FY 2025

Enterprise Value

$6.6B

Debt / EBITDA

1.2x

FY 2025

EV / EBITDA

-74.9x

Employees

—